Drug Type Monoclonal antibody |
Synonyms AAB 002, AAB002 |
Target |
Action inhibitors, stimulants |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 1 | United States | - | |
| Alzheimer Disease | Phase 1 | United States | - |






